Mangoceuticals rescinds IP purchase and consulting pacts, cancels 1.65M shares

MANGOCEUTICALS, INC.

On May 22, 2025, entered rescission agreements with ArcStone, Smokeless, and Strategem.
ArcStone retains 50,000 shares; remaining 50,000 cancelled for consulting services.
Smokeless Technology cancels all 1,600,000 shares issued for oral-pouch IP acquisition.
Strategem Solutions waives issuance of 120,000 shares and forfeits monthly cash fees.
No material termination penalties except the 50,000 ArcStone shares retained.

item 1.01item 1.02item 2.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.